SUN PHARMACEUTICAL INDUSTRIES
Back to Cashflow Statement
|
SUN PHARMACEUTICAL INDUSTRIES Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹-6,710 Cr | ₹2,376 Cr | ₹-5,193 Cr | ₹-5,980 Cr | ₹-5,715 Cr |
What is the latest Cash Flow from Financing Activities ratio of SUN PHARMACEUTICAL INDUSTRIES ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2024 | ₹-6,710 Cr |
Mar2023 | ₹2,376 Cr |
Mar2022 | ₹-5,193 Cr |
Mar2021 | ₹-5,980 Cr |
Mar2020 | ₹-5,715 Cr |
How is Cash Flow from Financing Activities of SUN PHARMACEUTICAL INDUSTRIES Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2024 | ₹-6,710 Cr | Negative | |
Mar2023 | ₹2,376 Cr | Positive | |
Mar2022 | ₹-5,193 Cr | Negative | |
Mar2021 | ₹-5,980 Cr | Negative | |
Mar2020 | ₹-5,715 Cr | - |
Compare Cash Flow from Financing Activities of peers of SUN PHARMACEUTICAL INDUSTRIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SUN PHARMACEUTICAL INDUSTRIES | ₹443,018.7 Cr | -0.4% | 4.7% | 60.2% | Stock Analytics | |
DIVIS LABORATORIES | ₹144,299.0 Cr | -1.1% | 11% | 43.2% | Stock Analytics | |
CIPLA | ₹132,316.0 Cr | -1.3% | 2.8% | 33.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹108,579.0 Cr | -2.3% | -7.8% | 14.4% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹106,092.0 Cr | -5.7% | -12.6% | 68.7% | Stock Analytics | |
MANKIND PHARMA | ₹97,396.6 Cr | -2.7% | 6.6% | 33.4% | Stock Analytics |
SUN PHARMACEUTICAL INDUSTRIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SUN PHARMACEUTICAL INDUSTRIES | -0.4% |
4.7% |
60.2% |
SENSEX | 0.3% |
3% |
23.3% |
You may also like the below Video Courses